LINICAL-PHARMACOLOGICAL BASIS OF CARBAMAZEPINE USAGEIN ALCOHOLISM COMPLEX THERAPY



Cite item

Full Text

Abstract

Carbamazepine main clinical-pharmacological characteristics are reviewed from the point of view its use in the alcoholism complex therapy. Its efficacy and safety is the same as in barbiturates, benzodiazepines, chlormethiazole and tiapride. Carbamazepine should be the drug of choice in patients with the risk of withdrawal seizures. In the alcohol withdrawal syndrome the combination of carbamazepine and other drugs (tiapride orchlormethiazole, in particularly is indicated. Carbamazepine has some preference compared to barbiturates and benzodiazepines: lack of addictiveness, sedation and cataleptic effects, cognitive suppression, cross-tolerance. Because of immunomodulating, anti-tumor, analgesic, antidiuretic, hepatoprotective and neurotropic effects carbamazepine may be used in the complex treatment of somatically complicated alcoholic patients.

Full Text

КЛИНИКО-ФАРМАКОЛОГИЧЕСКОЕ ОБОСНОВАНИЕ ПРИМЕНЕНИЯ КАРБАМАЗЕПИНА В КОМПЛЕКСНОЙ ТЕРАПИИ АЛКОГОЛИЗМА
×

About the authors

Alexander G Sofronov

I.I. Mechnikov Nord-West Medical University

191015, Saint-Petersburg, Kirochnaya street,41

Alexei Y Egorov

1) I.I. Mechnikov Nord-West Medical University; 2) St. Petersburg State University; 3) I.M. Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences

Email: draegorov@mail.ru
2) Medical Faculty 1) 191015, Saint-Petersburg, Kirochnaya street,41; 2) Saint-Petersburg, 199034, Vasilevsky Island,21-st line, 8а; 3) St. Petersburg, 19422, Тоrez Street, 44

References

  1. Авербах Я.К., Смирнов В.Е. Социальный прогноз и особенности терапии больных эпилепсией, осложненной алкоголизмом // Клинические аспекты социальной реадаптации психически больных. Л., 1976. С.107‒113.
  2. Альтшуллер В.Б. Антиконвульсанты как средство подавления патологического влечения к алкоголю / Доклад на симпозиуме «Нейропсихотропные препараты». М., 1994.
  3. Альтшуллер В.Б. Женский алкоголизм / Лекции по наркологии. Изд. 2-е, перераб. и расшир. [Под ред. Н.Н. Иванец]. М.: Нолидж, 2000. С.116‒133.
  4. Арана Д., Розенбаум Дж. Фармакотерапия психических расстройств. М.: БИНОМ. 2004. С. 241‒252.
  5. Болдырев А.И. Эпилепсия у взрослых. М.: Медицина,1984. 288 с.
  6. Вольф К. Медикаментозное лечение эпилепсии [Под редакцией П.А. Темина, М.Ю. Никанорова]. Диагностика и лечение эпилепсий у детей. М.: Можайск-Терра, 1997. С. 531–581.
  7. Ерышев О.Ф., Рыбакова Т.Г., Балашова Т.Н. Клинико-психологические особенности ремиссий при алкоголизме. / Психологические исследования и психотерапия в наркологии. Л., 1989. С. 16‒32.
  8. Ерышев О.Ф. Этапы течения ремиссий при алкоголизме и профилактика рецидивов: Автореф. дисс. докт. мед. наук,1998 г.
  9. Жислин С.Г. Очерки клинической психиатрии. М.: Медицина, 1965. 320 с.
  10. Крепелин Э. Введение в психиатрическую клинику. М.: БИНОМ, 2004. С 142‒144.
  11. Осипов В.П. Руководство по психиатрии. М.-Л., 1931.596 с.
  12. Пятницкая И.Н. Злоупотребление алкоголем и начальная стадия алкоголизма. М.: Медицина, 1988. 288 с.
  13. Сметанников П.Г. Психиатрия. Руководство для врачей. Изд. 3-е, перераб. и дополн. СПб: СПбМАПО, 1996.496 с.
  14. Софронов А.Г. Опиатная наркомания. Изд. Воен.-мед. акад. СПб, 1998. 57 с.
  15. Софронов А.Г. Клинико-экспериментальное обоснование новых подходов к оказанию психиатрической и токсикологической помощи при злоупотреблении опиатами: Автореф. дис. ...докт. мед. наук, СПб, 1995. 41 с.
  16. Хохлов Л.К. Биологические аспекты алкоголизма при эпидемиологическом исследовании // Биологические основы алкоголизма. М.: МЗ СССР, 1984. С 18‒24.
  17. Цымбал Е.И. Особенности развития алкогольно-барбитуровой политоксикомании у лиц, перенесших черепно-мозговую травму. // Актуальные вопросы наркомании (тезисы научных докладов). Омск, 1982. С. 194‒197.
  18. Шумский Н.Г. Алкоголизм. Руководство по психиатрии [под ред. А.В. Снежневского]. М.: Медицина,1983. Т. 2. С. 251‒328.
  19. Энтин Г.М., Крылов Е.Н. Клиника и терапия алкогольных заболеваний. М.: Изд-во Московского НИИ психиатрии МЗ РФ, 1994. Т. 2. С. 40‒42.
  20. Agricola R. Mazzarino M, Urani R. Treatment of acute alcohol withdrawal syndrome with carbamazepine: A double-blind comparison with tiapride // J. Int. Med. Res. 1982. Vol. 10. P. 160‒165.
  21. Аkiskal Н.S. А ргороsed clinical арргоасh to сhronic аnd геsistant depression: evaluation and treatment // J. Clin. Psichiat. 1985. Vol. 46, N. 2. Р. 32‒37.
  22. А1tегman А.J., Ауге F.R., Williford W.O. Diagnostic validation of conjoint schizophrenia and alcoholism // J. С1in. Рsychiat. 1984. Vol. 45, N. 7. Р. 300‒303.
  23. Bonhoeffer K. Zur Frage fortschrittenden und stationaren Wahnbildungen bei narkotischen Dauervergittungen // Allg. Z. Psych. 1926. Bd. 84. P. 38‒51.
  24. Bjorkvist, S.-E., M. Isohanni, R. Makela & Malinen L. Ambulant treatment of alcohol withdrawal symptoms with carbamazepine: a formal multicentre double-blind comparison with placebo // Acta psyhiat. Scand. 1976. Vol. 53. P. 333‒342.
  25. Chu N.S. Carbamazepine: prevention of alcohol withdrawal seizures // Neurology. 1979 Oct. Vol. 29(10). P. 1397‒1401.
  26. Costa C., Martella G., Picconi B. et al. Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia // Stroke. 2006. Vol. 37, N5. P. 1319‒1326.
  27. Craig R.J., Olson R.E. Changes in psychological functioning in opiate and cocaine addicts following short-term hospital-based treatment for drug abuse // Alcohol. Treat. Quart.1988. Vol.5, N 1/2. P. 273‒284.
  28. deOliveria I.R., daRocha F.P., Pereira E.L. et al. Combined carbamazepinne-buspirone treatment of alcohol dependence // J. Clin Psychiatry. 1993. Vol. 54. P. 488.
  29. Drake R.E., Mercer Me Fadden C., Mueser K.T., et al. Review of integrated mental substance abuse treatment for patients with dual disorders // Schizophr. Bull. 1998. Vol. 24(4). P. 589‒608.
  30. Flygenring J., Hansen J., Holst B. et al. Treatment of alcohol withdrawal symptoms in hospitalized patients // Acta Psy chiatr Scand. 1984. Vol. 69. P. 398‒408,
  31. Freed E.X. Alcoholism and schizophrenia: the search for perspective // J. of Studies on Alcohol. 1975. Vol. 40. P. 89‒116.
  32. Frye M.A., Salloum I.M. Bipolar disorder and comorbid alcoholism: prevalence rate and treatment considerations // Bipolar Disord. 2006 Dec. Vol. 8(6). P. 677‒685.
  33. Franz M., Dlabal H., Kunz S. et al. Treatment of alcohol withdrawal: tiapride and carbamazepine versus clomethiazole // Eur Arch Psychiatry Clin Neurosci. 2001. Vol. 251. P. 185‒192.
  34. Gammer H. Karbamazepin vid alkoholbetingade intoxikationstillstand // Lakartibingen. 1976. Vol. 73. P. 2819‒2820.
  35. Hara Y., Nakajima M., Miyamoto K., Yokoi T. Morphine glucuronosyltransferase activity in human liver microsomes is inhibited by a variety of drugs that are co-administered with morphine // Drug Metab. Pharmacokinet. 2007. Vol. 22, N2. P. 103‒112.
  36. Hesselbrock V.M., Hesselbrock M.N., Stabenau J.R. Alcoholism in men patients subtyped by family history and antisocial personality // J. Stud. Alcohol. 1985. Vol. 46. P. 59‒64.
  37. Honda K., Nishimiya J., Sato H. et al. Transient splenial lesion of the corpus callosum after acute withdrawal of antiepileptic drug: a case report // Magn. Reson. Med. Sci. 2006. Vol. 5, N4. P. 211‒215.
  38. Johnson M.E., Brems C., Burke S. Recognizing comorbidity among drug user in treatment // Amer. J. Drug and Alcohol Abuse. 2002. Vol. 28. P. 243‒261.
  39. Kraemer K.L. Conigliaro J., Saitz R. Managing alcohol withdrawal in the elderly // Drugs Aging. 1999 Jun. Vol. 14(6). P. 409‒425.
  40. Lepin J.P., Pelissolo A. Social phobia and alcoholism: a complex relationship // J. Affect. Dis. 1998. Vol. 50, Supp l.l. P. 23‒28.
  41. Lucht M., Kuehn K.U., Armbruster J. et al. Alcohol withdrawal treatment in intoxicated vs non-intoxicated patients: a controlled open-label study with tiapride/carbamazepine, clomethiazole and diazepam // Alcohol & Alcoholism. 2003. Vol.38, No.2. P. 168‒175.
  42. Luszczki J.J., Czuczwar M., Gawlik P. Influence of NG- nitro-L-arginine on the anticonvulsant and acute adverse effects of some newer antiepileptic drugs in the maximal electroshock-induced seizures and chimney test in mice // Pharmacol. Rep.2006. Vol. 58, N6. P. 955‒960.
  43. Malcolm R., Ballenger J.C., Sturgis E.T., Anton R.F. Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal // Am. J. Psychiatry.1989. Vol. 146. P. 617‒621.
  44. Malcolm R., Myrick H., Roberts J. et al. The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial // J. Gen Intern Med. 2002. Vol. 17. P. 349‒355.
  45. Meng Q.W., Zhao C.H., Xi Y.H. et al. Inhibitory effect of carbamazepine on proliferation of estrogen-dependent breast cancer cells // Ai Zheng. 2006. Vol. 25, N8. P. 967‒973.
  46. Moretti R., Torre P., Antonello R.M. et al. Peripheral neuropathy in hepatitis C virus-related mixed cryoglobulinaemia: existing treatments and a positive symptomatic response to oxcarbazepine // Funct. Neurol. 2006. Vol. 21, N3. P.137‒140.
  47. McQuarrie, D.G., Fingl E. Effects of single doses and chronic administration of ethanol on experimental seizures in mice // J. Pharmacol. Exp. Ther. 1958. Vol. 124. P. 264‒271.
  48. Mueller T.I., Robert L.S., Rudden S. A Double-Blind, Placebo-Controlled Pilot Study of Carbamazepine for the Treatment of Alcohol Dependence // Alcoholism: Clinical and Experimental Research. 1997. Vol. 21, No.1, February. P. 149–162.
  49. Młodzikowska-Albrecht J., Steinborn B., Zarowski M. Cytokines, epilepsy and epileptic drugs--is there a mutual influence? // Pharmacol. Rep. 2007. Vol. 59, N2. P. 129‒138.
  50. Nowakowska E., Kus K., Czubak A. et al. Some behavioral effects of carbamazepine – comparison with haloperidol // J. Physiol. Pharmacol. 2007. Vol.58, N2. P. 253‒264.
  51. Persinger M.A. Subjective improvement following treatment with carbamazepine (Carbamazepine) for a subpopulation of patients with traumatic brain injuries // Percept Mot Skills. 2000. Vol. 90. P. 37–40.
  52. Polycarpou A., Papanikolau P., Ionnidis J.P.A., Contopoulos-Ioannidis D.G. Anticonvulsants for alcoholwithdrawal. Cochrane Database of Systematic Reviews2007, Issue 3. Art. No.: CD005064. doi: 10.1002/14651858. CD005064. pub2.
  53. Poutanen, P. Experience with carbamazepine in the treatment of withdrawal symptoms in alcohol abusers // Brit. J. Addict. 1979. Vol. 74. P. 201‒204.
  54. Primm A.B., Tzolova L.L., Taylor C.M. An integrated approach for dually diagnosed patients in a substance abuse treatment program: Case presentation // Subst. Abuse. 2000. Vol. 21, N 2. P. 121.
  55. Rach B.J., Dixon L., Gearon J. Awareness of substance abuse problems among dually - diagnosed psychiatric inpatients // J. Psychoact. Drugs. 1999. Vol 31, N l. P. 51‒53.
  56. Regier D.A., Farmer M.E., Rae D.S. et al. Comorbidity of mental disorders with alcohol and other abuse: results from the Epidemiological Catchment Area Study // J. Am. Mod. Ass. 1990. Vol. 264. P. 2511‒2519.
  57. Rho J.M., Shankar R. The pharmacologic basis of antiepileptic drug action // Epilepsia. 1999. Vol. 40. P. 1471–1483.
  58. Ritola, E., Malinen L. A double-blind comparision of carbamazepine and clomethiazole in the treatment of alcohol withdrawal syndrome // Acta psychiat. Scand. 1981. Vol. 64. P. 254‒259.
  59. Roy A., Dejong J., Lamparski D. et al. Mental disorders among alcoholics. Relationschip to age of onst and cerebrospinal fluid neuropeptides // Arch. Gen. Psychiatry. 1991. Vol. 48. P. 423‒427.
  60. Shetty A.J., Narayana K., Bairy K.L. et al. The effect of carbamazepine on sperm counts in Wistar rats--reflecting upon its mitogenic potential // Reprod. Biol. 2007. Vol. 7, N2. P. 177‒181.
  61. Schneider P.B., Burner M., Pagani J.P. 1st results of anti-epileptic and psychotropic effectss of Carbamazepine in ambulatory practice // Encephale. 1965. Vol. 54. P. 433–439.
  62. Sonoda T., Goto Y., Taen S. Therapeutic effect of carbamazepine, a new antiepileptic agent, on epileptic seizures and emotional disorders of epileptics // No To Shinkei 1965. Vol. 17. P. 1161–1168.
  63. Stanhope J.M. The use of carbamazepine in chormethiazole-modified withdrawal from alcohol // Australian Drug and Alcohol Review. 1989. Vol. 8. P. 5–8.
  64. Stuppaeck C.H., Pycha R., Miller C. et al. Carbamazepine versus oxazepam in the treatment of alcohol withdrawal: A double-blind study // Alcohol Alcohol. 1992. Vol. 27. P. 153‒158.
  65. Sun G.C., Werkman T.R., Wadman W.J. Kinetic changes and modulation by carbamazepine on voltage-gated sodium channels in rat CA1 neurons after epilepsy // Acta Pharmacol Sin.2006. Vol. 27, N 12. P. 1537‒1546.
  66. Thome J., Wiesbeck G.A., Vince G.H. Carbamazepin in der Behandlung Alkoholentzugssyndroms – Eine Ubersicht zum aktuellen Forschungsstand // Fortschr Neurol Psychiatr. 1994. Vol. 62. P. 125‒133.
  67. Vornik L.A., Brown E.S. Management of comorbid bipolar disorder and substance abuse // J. Clin Psychiatry. 2006. Vol. 67, Suppl 7. P. 24-30.
  68. Vuckovic S., Tomic M., Stepanovic-Petrovic R. et al. Peripheral antinociception by carbamazepine in an inflammatory mechanical hyperalgesia model in the rat: a new target for carbamazepine? // J. Pharmacol. Sci. 2006. Vol. 100, N4. P. 310‒314.
  69. Willens T., Biederman J., Abrantes A. et al. The relationschip of juvenile psychiatric and substance disorders // Biol. Psychiatr. 1997. Vol. 42, N 1, Suppl. C. P. 145.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2013 Sofronov A.G., Egorov A.Y.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 75562 от 12 апреля 2019 года.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies